News

Wockhardt Hospitals, Mira Road has initiated a month-long Organ Donor Awareness Campaign, which has started from July 11 and ...
Daxor’s new rapid, lightweight, Blood Volume Analysis system receives US FDA 510(k) clearance: Oak Ridge, Tennessee Monday, August 11, 2025, 18:00 Hrs [IST] Daxor Corporation, t ...
US FDA accepts Arvinas’ NDA for vepdegestrant to treat ESR1m, ER+/HER2- advanced breast cancer: New Haven, Connecticut Monday, August 11, 2025, 17:00 Hrs [IST] Arvinas, Inc., a ...
Exports of Ayush and herbal products for the first three months of FY26 has reported a marginal growth of 0.58%, as compared ...
US FDA approves Nyxoah’s Genio system for the treatment of obstructive sleep apnoea: Mont-Saint-Guibert, Belgium Monday, August 11, 2025, 15:00 Hrs [IST] Nyxoah SA, a medical te ...
BioNTech reaches agreement to get a non-exclusive license for mRNA-based Covid-19 and/or influenza products and resolve patent litigation with CureVac & GSK: Mainz, Germany Monday ...
Our Bureau, Mumbai Monday, August 11, 2025, 16:15 Hrs [IST] Entod Pharmaceuticals, a pioneer in ophthalmic, ENT, and dermatol ...
FOPE with CIPI team-ups with DCGI to foster dialogue and bolster collaboration with pharma sector: Our Bureau, Bengaluru Monday, August 11, 2025, 13:30 Hrs [IST] Federation of Pha ...
Assembly Biosciences announces positive interim results from phase 1b study of ABI-5366, a long-acting helicase-primase inhibitor for HSV type 2 with recurrent genital herpes ...
HOPE & NRx Pharma receive final clearance from Florida's AHCA to proceed to closing of Dura Medical acquisition: Miami Monday, August 11, 2025, 13:00 Hrs [IST] HOPE Therapeutics, ...
Clearmind Medicine reports publication of international patent application for novel combination therapy targeting obesity & high blood sugar: Vancouver, Canada Monday, August 11, ...
L V Prasad Eye Institute (LVPEI) is recognized as one of the leading centres globally for corneal neurotization surgery has performed over 40 procedures, achieving surgical success rates comparable to ...